CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
CAR-CQ0451 | Anti-CEACAM5 (161 (NCRC16)) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 161 (NCRC16) | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0452 | Anti-CEACAM5 (CBXC-2571) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2571 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0453 | Anti-CEACAM5 (CBXC-2623) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2623 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0454 | Anti-CEACAM5 (Arcitumomab) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | Arcitumomab | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0455 | Anti-CEACAM5 (By114) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | By114 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0456 | Anti-CEACAM5 (C365D3(NCRC23)) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C365D3(NCRC23) | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0457 | Anti-CEACAM5 (C66/1009) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C66/1009 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0458 | Anti-CEACAM5 (C66/1030) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C66/1030 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0459 | Anti-CEACAM5 (C66/1260) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C66/1260 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0460 | Anti-CEACAM5 (C66/1291) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C66/1291 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0461 | Anti-CEACAM5 (C66/1292) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C66/1292 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0462 | Anti-CEACAM5 (C66/195) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Monkey | C66/195 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0463 | Anti-CEACAM5 (C66/261) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Primate | C66/261 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0464 | Anti-CEACAM5 (CB30) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CB30 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0465 | Anti-CEACAM5 (CEA31) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Primate | CEA31 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0466 | Anti-CEACAM5 (COL-1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | COL-1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0467 | Anti-CEACAM5 (PARLAM4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | PARLAM4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0468 | Anti-CEACAM5 (SPM330) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Monkey | SPM330 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0469 | Anti-CEACAM5 (SPM506) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Monkey | SPM506 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0470 | Anti-CEACAM5 (SPM541) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Primate | SPM541 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0471 | Anti-CEACAM5 (SPM551) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Primate | SPM551 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0472 | Anti-CEACAM5 (SPM584) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | SPM584 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0473 | Anti-CEACAM5 (CBXC-1215) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1215 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0474 | Anti-CEACAM5 (CCM661) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CCM661 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0475 | Anti-CEACAM5 (CCAM5-1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CCAM5-1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0476 | Anti-CEACAM5 (C19) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C19 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0477 | Anti-CEACAM5 (CBXC-2945) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2945 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ0478 | Anti-CEACAM5 (CBXC-1942) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1942 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3875 | Anti-CEACAM5 (161 (NCRC16)) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 161 (NCRC16) | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3876 | Anti-CEACAM5 (CBXC-2571) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2571 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3877 | Anti-CEACAM5 (CBXC-2623) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2623 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3878 | Anti-CEACAM5 (Arcitumomab) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | Arcitumomab | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3879 | Anti-CEACAM5 (By114) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | By114 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3890 | Anti-CEACAM5 (COL-1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | COL-1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3891 | Anti-CEACAM5 (PARLAM4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | PARLAM4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3892 | Anti-CEACAM5 (SPM330) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Monkey | SPM330 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3893 | Anti-CEACAM5 (SPM506) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Monkey | SPM506 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3894 | Anti-CEACAM5 (SPM541) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Primate | SPM541 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3895 | Anti-CEACAM5 (SPM551) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Primate | SPM551 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ3896 | Anti-CEACAM5 (SPM584) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | SPM584 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MOREAngiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORETRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE